Sorry - There were no pages found that contain that search phrase.
 |
|
|
|
|
|
Treatment |
|
Location |
|
Last Updated |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Mobile, AL USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme |
|
Mobile, AL USA |
|
04/11/2008 |
|
|
|
Details |
|
A Phase II Trial of Erlotinib (OSI-774) and Sorafenib (BAY 43-9006) for Patients With Progression or Recurrent Glioblastoma Multiforme |
|
Birmingham, AL USA |
|
08/26/2007 |
|
|
|
|
|
Details |
|
A Phase I, Open Label Study of AT-101 (Gossypol) Plus Radiotherapy and Temozolomide and of AT-101 Plus Adjuvant Temozolomide for Patients With Newly-Diagnosed Glioblastoma Multiforme |
|
Birmingham, AL USA |
|
08/19/2007 |
|
|
|
Details |
|
A Phase II Open-Label, Multiple-Dose Study of Intracavitary Administered 131I-TM-601 in Adult Patients with Recurrent High-Grade Glioma |
|
Birmingham, AL USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
A Phase II Open-Label, Multiple-Dose Study of Intracavitary Administered 131I-TM-601 in Adult Patients with Recurrent High-Grade Glioma |
|
Birmingham, AL USA |
|
08/18/2007 |
|
|
|
Details |
|
Phase 1 Trial Gamma Knife For Primary Brain Tumors - Gliomas. |
|
Birmingham, AL USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
A Phase I Imaging and Safety Study of Intravenous 131-I-TM-601 Labelled Chlorotoxin In Patients with Recurrent or Refractory Somatic and/or Cereberal Metastatic Solid Tumors |
|
Birmingham, AL USA |
|
06/04/2007 |
|
|
|
Details |
|
Phase I/II Study of Intravenous Infusion of Tetra-o-Methyl Nordihydroguaiaretic Acid (EM-1421) in Subjects With Recurrent High Grade Glioma |
|
Birmingham, AL USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Birmingham, AL USA |
|
05/01/2007 |
|
|
|
Details |
|
Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma
|
|
Birmingham, AL USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Talampanel, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
|
Birmingham, AL USA |
|
04/29/2007 |
|
|
|
Details |
|
Phase II Trial of Talampanel in Conjunction With Radiation Therapy With Recurrent and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Birmingham, AL USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Birmingham, AL USA |
|
04/29/2007 |
|
|
|
Details |
|
A Feasibility Assessment and a Phase I/II Trial of MLN518 (Tandutinib) for Treatment of Patients with Recurrent Glioblastoma |
|
Birmingham, AL USA |
|
04/28/2007 |
|
|
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Birmingham, AL USA |
|
06/26/2006 |
|
|
|
Details |
|
The use of the Gliasite radiation therapy system for malignant gliomas |
|
Mobile , AL |
|
12/03/2005 |
|
|
|
|
|
Details |
|
A Staged Phase 1 Study of the Treatment of Malignant Glioma with G207, a Genetically Engineered HSV-1, Followed by Radiation Therapy |
|
Birmingham, AL USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Birmingham, AL USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Mobile, AL USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Tucson, AL USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors
|
|
Birmingham, AL USA |
|
11/26/2005 |
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Birmingham, AL USA |
|
11/06/2005 |
|
|
|
|
|
Details |
|
Radiosurgery with the Varian Trilogy system for benign or malignant brain tumors |
|
Mobile , AL |
|
11/06/2005 |
|
|
|
Details |
|
NCCTG Phase 2 Trial of CCI-779 (Temsirolimus) in Recurrent Glioblastoma Multiforme |
|
Mobile , AL |
|
11/06/2005 |
|
|
|
|
|
Details |
|
A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy |
|
Mobile, AL |
|
11/06/2005 |
|
|
|
Details |
|
SWOG (RTOG) 98-13 randomized trial of RT + Temozolomide vs RT + BCNU, versus RT+ Tem + BCNU |
|
Mobile , AL |
|
11/06/2005 |
|
|
|
|
|
Details |
|
Z0300: Phase III Randomized Trial of the Role of Whole Brain Radiation Therapy in Addition to Radiosurgery in the Management of Patients with One to Three Cerebral Mets |
|
Mobile , AL |
|
11/06/2005 |
|
|
|
